Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 to 79 Women only

Using Pantoprazole to Prevent Nausea After Gynecologic Surgery

Official title: Preoperative Use of Pantoprazole for Prevention of Post Operative Nausea and Vomiting in Gynecologic Surgery

Run by United States Naval Medical Center, Portsmouth · NCT06488001 · Data updated 2026-11-12

This study is testing if giving pantoprazole can help women avoid nausea and vomiting after gynecologic surgery.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years to 79 Years
SexWomen only
Enrollment132 (estimated)
SponsorUnited States Naval Medical Center, Portsmouth
Federal
Locations1 site (Portsmouth, Virginia)
StatusRecruiting
StartedAugust 26, 2022
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedMay 21, 2025
Trial IDNCT06488001 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 18 to 79 undergoing elective gynecologic surgery under general anesthesia.

Probably not a fit

Patients who are pregnant, have gastrointestinal diseases requiring ongoing management, or have a history of severe PONV may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of pantoprazole, a proton pump inhibitor, in reducing postoperative nausea and vomiting (PONV) in women undergoing elective gynecologic surgery. Participants will be randomly assigned to receive either pantoprazole or a placebo, with medication administered before and after surgery. The study will utilize a double-blind design to ensure unbiased results, and postoperative nausea will be assessed using a visual analog scale. The trial is part of an enhanced recovery after surgery (ERAS) protocol that includes standard anti-nausea medications.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the incidence of postoperative nausea and vomiting, improving recovery experiences for patients.

How similar studies have gone: Previous studies have shown varying degrees of success with similar approaches, but this specific use of pantoprazole for PONV prevention is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Undergoing elective gynecological surgery by either an open abdominal or minimally invasive approach (to include both endoscopic and vaginal). Procedure must be performed under general anesthesia.

Exclusion Criteria:

* Pregnant,
* Patients with gastrointestinal disease requiring ongoing medical management.
* Prior gastrointestinal surgery with the exception of diagnostic procedures, appendectomy and cholecystectomy.
* Patients with a history of H2 receptor blocker use, proton pump inhibitor use or other GERD specific therapy within 30 days of surgery.
* Any patient identified by their surgical care team as having a history of PONV warranting additional perioperative prophylaxis.
* Known r suspected malignancy
* Lactose intolerance

Where it's running

  • Naval Medical Center Portsmouth
    Portsmouth, Virginia, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.